Table 5

MUC5B promoter variant (rs35705950) genotypes and minor allele frequencies (MAF) in individuals with IPF-associated mutations

 IPFCOPD
Mutation (n=14)No Mutation (n=118)Total (n=132)Mutation (n=6)No Mutation (n=186)Total (n=192)
G/G6 (43%)57 (48%)63 (48%)6 (100%)140 (75%)146 (76%)
G/T8 (57%)57 (48%)65 (49%)0 (0%)44 (24%)44 (23%)
T/T0 (0%)4 (3%)4 (3%)0 (0%)2 (1%)2 (1%)
MAF8 (29%)*65 (28%)*73 (28%)†0 (0%)48 (13%)48 (13%)†
  • p Value IPF versus population (MAF 9%)=6.7 e-12; COPD versus population=0.09.12

  • p Value: COPD no mutation versus mutation=0.38.

  • *p Value IPF mutation versus no mutation=1.0.

  • †p Value of IPF versus COPD=1.9 e-06.

  • COPD, chronic obstructive pulmonary disease; IPF, idiopathic pulmonary fibrosis.